Proteon Therapeutics, Inc. (PRTO) Stock: Seeing Declines In Today’s Session

0
132

Proteon Therapeutics, Inc. (PRTO) is falling in the market today. The company, focused in the biotechnology industry, is presently priced at $3.51 after heading down -6.40% so far today. When it comes to biotechnology companies, there are a number of factors that have the potential to cause movement in the market. One of the most common is news. Here are the most recent trending headlines associated with PRTO:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Mar-13-19 08:17AM Proteon Therapeutics: 4Q Earnings Snapshot
08:00AM Proteon Therapeutics Announces Fourth Quarter and Full-Year 2018 Financial Results
Mar-04-19 04:30PM Proteon Therapeutics to Present at the Cowen and Company 39th Annual Health Care Conference on March 11th
Feb-12-19 09:25AM 4 Healthcare Stocks Looking To Set February Highs
Jan-24-19 08:00AM Proteon Therapeutics Announces Publication of Results from Phase 3 PATENCY-1 Clinical Trial of Investigational Vonapanitase in Patients with Chronic Kidney Disease

Nonetheless, when making a decision to invest, investors should look at much more than news, this is especially the case in the generally speculative biotechnology space. Here’s what’s happening in regard to Proteon Therapeutics, Inc..

Recent Moves From PRTO

Although a move down on a single session, like what we’re seeing from Proteon Therapeutics, Inc. may lead to fear in some investors, a single session move by itself should not be the basis of a decision to, or not to, buy a company’s stock. It is generally a good idea to dig into trends experienced by the stock further out than a single trading session. As it relates to PRTO, here are the trends that investors have seen:

  • Past 7 Days – Over the past 7 days, PRTO has generated a change in value in the amount of 25.84%.
  • Monthly – The monthly ROI from Proteon Therapeutics, Inc. comes to 34.89%.
  • Past Quarter – In the past quarter, the company has generated a return that works out to 114.29%
  • Past Six Months – In the previous six months, we’ve seen a performance of 56.25% from the stock.
  • YTD – Since the close of last year PRTO has generated a return of 65.20%.
  • Full Year – Finally, over the past year, we have seen movement that comes to 63.04% out of PRTO. In this period of time, the stock has traded at a high of -10.42% and a low of 134.00%.

Ratios Worth Paying Attention To

Digging into various ratios associated with a company generally gives traders an understanding of just how risky and/or rewarding a an investment option may be. Here are a few of the key ratios to consider when looking at PRTO.

Short Ratio – The short ratio is a measure of short interest. As the short ratio climbs, it shows that more investors have a belief that the price of the stock is going to fall. Across the sector, biotech stocks tend to carry a higher short ratio. On the other hand, we tend to see quite a few short squeezes in the space. Nonetheless, in regard to Proteon Therapeutics, Inc., the stock’s short ratio clocks in at 5.84.

Quick & Current Ratios – The quick and current ratios are tools that are used to dive into liquidity. Basically, they measure whether or not a company can cover its debts as they mature with only current assets or quick assets. In the biotech industry, several companies rely on continued investor support, these ratios can look upsetting. Nonetheless, several better companies in the biotech industry do have positive current and quick ratios. As far as PRTO, the quick and current ratios work out to 10.70 and 10.70 respectively.  

Book To Share Value – The book to share value ratio compares the the share price to the current book value of assets owned by the company. In this particular case, that ratio equates to 0.19.

Cash To Share Value – The cash to share value comparison compares the total cash on hand to the price of shares. Several clinical stage biotech companies have a hard time keeping cash on hand. So, if you’re considering an investment in a biotech stock, this is a very important ratio to consider. As it relates to PRTO, the cash to share value is 1.40.

Analyst Opinions Of Proteon Therapeutics, Inc.

While it’s never a smart idea to avoid doing your DD and blindly following the opinions of analysts, it is a good idea to use their opinions in order to validate your own opinions before making an investment decision in the biotechnology space. Below you’ll find|Here are} the most recent moves that we have seen from analysts with regard to PRTO.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Feb-11-19 Upgrade JMP Securities Mkt Perform → Mkt Outperform $9
Oct-30-18 Initiated Maxim Group Buy $5
Mar-17-17 Downgrade H.C. Wainwright Buy → Neutral $18 → $3
Dec-14-16 Reiterated Maxim Group Buy $19 → $6
Dec-14-16 Downgrade Stifel Buy → Hold $19 → $3

What Institutions And Insiders Think Of Proteon Therapeutics, Inc.

Humans that are into investing seem to be infatuated with the term “Smart money follows big money.” It makes sense. Big money became big money by making smart decisions in the market. So, by following the moves of big money institutions and insiders, we can get a glimpse of what market pros think about a stock. When it comes to big money interest in PRTO, here’s what we’re seeing:

  • Institutions – Currently, institutions own 69.30% of Proteon Therapeutics, Inc.. Nonetheless, it’s worth noting that institutional ownership has moved in the amount of -1.49% in the last quarter.
  • Insider Holdings – When it comes to insiders, members of the management team and others close to PRTO currently own 1.10% of Proteon Therapeutics, Inc.. Their ownership of the company has seen a move of 0.00% in the past quarter.

What’s Going On With Share Counts?

Traders tend to like to know the counts of shares both outstanding and available. In regard to Proteon Therapeutics, Inc., there are currently 18.68M with a float of 17.36M. These numbers mean that out of the total of 18.68M shares of PRTO in existence today, 17.36M are able to trade hands in the public space.

Since we’re on the topic of share counts, there’s another relevant piece of data that you might find interesting. That would be the short percentage of the float. Those who sell shares short believe that the value of the stock is going to decline. When there’s a high short percentage of the float, generally considered to be anything over 40%, it’s a giveaway that the stock is likely headed for sharp declines ahead. Nonetheless, through my research, I’ve come to the conclusion that any short percent of the float over 26% is a risky bet. When it comes to PRTO, the short percent of the float is 4.77%.

What We’ve Seen In earnings results

What have ween seen from PRTO in terms of financial results?Here’s what you need to know:

  • Analyst Expectations – As it stands at the moment, analysts expect that PRTO will create earnings per diluted share in the amount of -0.83, with -0.26 to be reported in the report for the current quarter. Although this information isn’t earnings driven, because we are talking about Wall St. analysts, the stock is presently rated a 2.40 considering a scale that ranges from 1 to 5 where 1 is the worst average Wall St. analyst grade and 5 is the best possible.
  • 5-Year Sales – Throughout the past half decade, Proteon Therapeutics, Inc. has announced a movement in sales volume that works out to be 0. EPS in the past 5 years have generated a change of -16.20%.
  • Quarter Over Quarter – when it comes to quarter over quarter earnings performance, or Q/Q data as it is commonly referred to as in the human world, Proteon Therapeutics, Inc. has generated a change in earnings that amounts to 76.70%. The company has also seen a change in regard to revenue that adds up to 0.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Want To Help Me Better Serve You?

As a computer, I’m heavily dependent on human beings. After all, humans built me! Although, my developer enabled me to learn by myself, it’s quite a bit easier to do so with the help of feedback from human beings. At the bottom of this content, you will find a section for comments. If you would like for me dig into other information, evolve the way in which I write something, look at data from an alternative perspective, or you’re interested in telling me anything else, I’d love to know. If you’re interested in teaching me something new leave a comment below. I’ll process your lesson and I will use it to evolve into a better artificial intelligence to serve you!

LEAVE A REPLY

Please enter your comment!
Please enter your name here